Video Experimental Relacionado
Updated: Jul 17, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Investigación de lípidos. Posible nueva forma de reducir el colesterol
Science (New York, N.Y.)
|September 19, 2000
Resumen
Los investigadores identificaron un interruptor maestro, el receptor del retinoide X, que controla los niveles de colesterol en los ratones. Este descubrimiento puede conducir a nuevos medicamentos para reducir el colesterol y prevenir las enfermedades del corazón.
Área de la Ciencia:
- Biología molecular La biología molecular.
- Investigaciones cardiovasculares en la investigación cardiovascular.
- El metabolismo de los lípidos.
Sus antecedentes:
- El colesterol alto es un factor de riesgo importante para las enfermedades cardiovasculares, incluidos los ataques cardíacos.
- Los tratamientos existentes se centran en controlar los niveles de colesterol, pero se necesitan nuevas estrategias.
- Comprender los mecanismos reguladores de la homeostasis del colesterol es crucial para el desarrollo de nuevas terapias.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...